NCI To Appoint Expert Group To Consider Standards For Outcomes Measurement.
Carroll Named Deputy Director At Huntsman; Pamer Leads Infectious Disease Service, MSKCC.
Oncology Nursing Society Names 15 To Advisory Panel.
IND-Exempt Trials May Need Special Review, HCFA Says.
NCI To Pilot Text Chat On CancerNet And CIS Sites.
Satcher Calls For Wider Use Of Smoking Prevention Efforts.
NIH Funds 11 New Grants In Women’s Health Research.
FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity.
M.D. Anderson, SWOG To Use Web-Based Software To Expand Access To Trials.
Polymer Platinate Begins Testing In Phase I Trial.
Abbott To Supply Quest With Immunoassay Tests.
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Brian Wolpin celebrates FDA approval of daraxonrasib in pancreatic cancer as the future of the field
- FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says - Trump weighs—and abandons—an executive order that would give OMB veto power over NIH grants
